| 生物活性 | |||
|---|---|---|---|
| 描述 | Mertansine (DM1) serves as a microtubulin inhibitor and is a maytansinoid designed for conjugation to antibodies to form antibody-drug conjugates (ADCs), aimed at reducing systemic toxicity associated with maytansine and improving tumor-specific delivery[1].[2]. | ||
| 实验方案 | |||
|---|---|---|---|
| 1mg | 5mg | 10mg | |
| 1 mM 5 mM 10 mM | 1.35mL 0.27mL 0.14mL | 6.77mL 1.35mL 0.68mL | 13.54mL 2.71mL 1.35mL | 
| 参考文献 | 
|---|
| [2]Lopus M. Antibody-DM1 conjugates as cancer therapeutics. Cancer Lett. 2011 Aug 28;307(2):113-8. |